Recently, Lei Ping, Deputy Director of the National Medical Products Administration, made a visit to Shanghai to delve into the groundbreaking progress of brain-computer interface medical devices. During his visit, he toured various entities, including enterprises, technology innovation hubs, national medical centers, and evaluation and testing facilities, to gain a comprehensive understanding of the current state of R&D, technological breakthroughs, clinical utilization, and industrial support services. Lei Ping underscored the importance of executing the strategies and blueprints set forth by the Party Central Committee, harnessing the supportive functions of platforms and institutions, advancing service checkpoints, expediting the conversion of research outcomes, and nurturing fresh growth engines for forthcoming industries. Additionally, he encouraged enterprises to persist in independent innovation, surmount challenges in core technologies, and proactively steer their development trajectories.